Search

Editas Medicine Inc

Ouvert

SecteurSoins de santé

2.88 0.35

Résumé

Variation du prix de l'action

24h

Actuel

Min

2.83

Max

2.95

Chiffres clés

By Trading Economics

Revenu

-19M

-25M

Ventes

-22M

2.8M

BPA

-0.26

Marge bénéficiaire

-882.444

Employés

87

EBITDA

-18M

-23M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+150% upside

Dividendes

By Acuity

Prochains Résultats

10 août 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

207M

500M

Ouverture précédente

2.53

Clôture précédente

2.88

Sentiment de l'Actualité

By Acuity

50%

50%

156 / 340 Classement par Healthcare

Editas Medicine Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

20 juil. 2026, 23:56 UTC

News

Brookdale Senior Living announced its second-quarter 2026 earnings release dates, boosting investor sentiment. Shares are trading higher in after-market hours.

20 juil. 2026, 23:56 UTC

News

Valero Energy Corp gains in after-market trading on strong earnings forecast, with projected EPS of $9.81 and revenue expectations of $35.95 billion.

20 juil. 2026, 23:51 UTC

News
Correlated Moves

Ally Financial shares are lower in after-market trading despite the board declaring a quarterly cash dividend of $0.30 per share.

20 juil. 2026, 23:51 UTC

Social Media
News

Magnolia Oil & Gas announced a $1 billion stock offering to fund the acquisition of WildFire Intermediate Holdings, resulting in a sharp decline in after-market hours.

20 juil. 2026, 23:46 UTC

News

Advanced Energy Industries gained after-market hours following $31 million in funding for the Idaho Advanced Energy Consortium's Nuclear Energy Corridor Tech Hub initiative.

20 juil. 2026, 23:46 UTC

News

Ross Stores announced 47 new locations but shares are trading lower in after-market hours following Monday's close. The company plans to open about 110 stores in 2026.

20 juil. 2026, 23:46 UTC

News

Monarch Casino & Resort Inc reports record Q2 revenue of $142.6 million and EPS of $1.78, trading higher in after-market hours.

20 juil. 2026, 23:46 UTC

News

Sweetgreen Inc shares are higher in after-market trading, despite ongoing concerns in the restaurant sector over a cyclospora outbreak linked to iceberg lettuce.

20 juil. 2026, 23:46 UTC

News

Warner Bros Discovery shares are lower in after-market hours as a judge pauses the $110 billion Paramount Skydance acquisition, extending legal uncertainty.

20 juil. 2026, 23:41 UTC

News
Event

Calix Inc's stock is lower in after-market trading following a mixed earnings report and a disappointing third-quarter outlook, alongside a class action lawsuit.

20 juil. 2026, 23:36 UTC

News

GameStop shares are lower in after-market hours as the company proposes a stock-based acquisition of eBay, introducing significant new debt and operational changes.

20 juil. 2026, 23:36 UTC

News
Correlated Moves

Invesco Ltd's shares rose during after-market hours, reflecting a modest increase since Monday's close, alongside gains in the Invesco S&P 500 High Dividend Low Volatility ETF.

20 juil. 2026, 23:36 UTC

News

Jazz Pharmaceuticals PLC will report second-quarter results on August 3, contributing to positive investor sentiment as shares trade higher after market hours.

20 juil. 2026, 23:32 UTC

News

Broadcom Inc. shares are higher in after-hours trading, driven by strong historical returns and potential growth from Meta Platforms' AI chip production plans.

20 juil. 2026, 23:26 UTC

News
Correlated Moves

Blackstone Inc. shares are higher in after-market trading following a $676 million investment in South Korea's Futronic, enhancing its technology portfolio.

20 juil. 2026, 23:16 UTC

News

Enphase Energy shares fell after TD Cowen cut its price target from $70 to $48, citing a challenging solar market and weaker demand. The stock was roughly flat in after-market trading.

20 juil. 2026, 23:16 UTC

News
Social Media

Alphabet Inc shares are higher in after-market hours as reports reveal plans for a new AI chip that may significantly outperform current models.

20 juil. 2026, 23:16 UTC

News

Quanta Services reported a $48 billion backlog, signaling strong revenue potential. Shares moved higher in after-market hours amid bullish analyst sentiment.

20 juil. 2026, 23:06 UTC

News

ServiceNow Inc. shares are trading lower in after-market hours amid bearish sentiment over potential disruptions from generative AI and rising Treasury yields.

20 juil. 2026, 23:06 UTC

News

Pomerantz LLP has filed a class action lawsuit against Lucid Group Inc, alleging securities fraud related to misleading statements about operational capabilities and performance.

20 juil. 2026, 23:06 UTC

News
Social Media

General Electric Co advances in aviation technology with a hybrid-electric flight demonstration and secures an engine deal with Philippine Airlines, shares higher after-market.

20 juil. 2026, 23:06 UTC

News

Geopolitical tensions, particularly between the U.S. and Iran, have impacted global consumer sentiment. Nike shares were little changed during after-market hours.

20 juil. 2026, 23:06 UTC

News

Yum Brands Inc shares declined after a report of reduced foot traffic at Taco Bell due to a parasite outbreak linked to lettuce supplied by a vendor.

20 juil. 2026, 23:02 UTC

News

Zions Bancorporation NA reported Q2 earnings of $452 million, or $3.05 per share, but shares are lower in after-market trading amid mixed results.

20 juil. 2026, 23:02 UTC

News

W. R. Berkley Corporation reported strong second-quarter earnings but missed revenue expectations. Shares declined during after-market hours amid notable volatility.

20 juil. 2026, 23:01 UTC

News

Coca-Cola Consolidated Inc shares rose during after-market hours, reflecting positive sentiment in the beverage sector despite earlier session volatility.

20 juil. 2026, 23:01 UTC

News

Karyopharm Therapeutics shares fell in after-market hours following the announcement of a leadership cash retention program aimed at key executives.

20 juil. 2026, 23:01 UTC

Social Media
News

Park Aerospace Corp reported first-quarter earnings of $0.17 per share, exceeding estimates, and is trading higher in after-market hours.

20 juil. 2026, 23:01 UTC

News
Event

Cracker Barrel completed a sale-leaseback for 26 locations, generating $77 million. Shares are trading higher after exceeding previous revenue guidance.

20 juil. 2026, 23:01 UTC

News
Social Media
Event

Crown Holdings reported second-quarter adjusted EPS of $2.49, exceeding estimates. The company raised its full-year EPS guidance, with shares higher in after-market hours.

Comparaison

Variation de prix

Editas Medicine Inc prévision

Objectif de Prix

By TipRanks

150% hausse

Prévisions sur 12 Mois

Moyen 7.2 USD  150%

Haut 15 USD

Bas 4 USD

Basé sur 7 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

7 ratings

5

Achat

1

Maintien

1

Vente

Sentiment

By Acuity

156 / 340Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Editas Medicine Inc

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 BRILLIANCE trial for Leber Congenital Amaurosis; and reni-cel, a clinical development gene-edited medicine to treat sickle cell disease and transfusion-dependent beta-thalassemia. In addition, the company is developing alpha-beta T cells for solid and liquid tumors; and gamma delta T cell therapies to treat cancer. It has a research collaboration with Juno Therapeutics, Inc. to develop engineered T cells for cancer; collaboration and nonexclusive license agreement with Genevant Sciences to develop Novel mRNA-LNP gene editing therapeuticsand strategic alliance and option agreement with Allergan Pharmaceuticals International Limited, as well as collaboration with Bristol Myers Squibb for research and development of alpha-beta T cell medicines for the treatment of cancer and autoimmune diseases. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.
help-icon Live chat